Peilin Tian

Peilin Tian

Auto-generated profile, based on publicly available information

Peilin Tian

School of Chemistry, UNSW Sydney, Hilmer Building (E10), Union Rd, UNSW Sydney, Kensington NSW 2033, Sydney, New South Wales, 2033, AUSTRALIA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2025 in Biofabrication
Verified
Journal Article
Open access
SRSara Romanazzo
Sara Romanazzo
PTPeilin Tian
Peilin Tian
GJGagan K Jalandhra
Gagan K Jalandhra
RDRiddhesh B Doshi
Riddhesh B Doshi
J. GoodingJ. Gooding
J. Gooding
KKKristopher A Kilian
Kristopher A Kilian
Breast cancer progression is a consequence of intricate dynamics between cells and their matrix in the tumor microenvironment. However, most in vitro models are not amenable to studying the behavior of multiple cell types within a defined matrix architecture. In this study, we demonstrate a microporous matrix where breast cancer cells and adipose derived stromal cells are integrated to evaluate crosstalk between matrix parameters and heterotypic cell populations. To do this, we leveraged two biofabrication techniques, granular suspension matrices and drop-on-demand bioprinting, to deposit multiple cell types in a reproducible format amenable to high-throughput screening. 3D gelatin-methacryloyl microgels were used to create a yield stress granular suspension bath with tunable interstitial volume to mimic the porosity and densities of healthy and fibrotic microenvironments. Invasive and non-invasive breast cancer cells (MCF-7 and MDA-MB-231) were bioprinted at the interface of the ADSC-laden granular matrix to probe invasive processes and heterotypic crosstalk as a tumor–stroma model. We focused on cancer cell migration through model fibrotic tissue and ADSC transformations into cancer associated fibroblasts. α-smooth muscle actin expression indicated that the high density microgel matrices are more conducive to ADSC-CAF transformations, which in turn influenced the expression of molecular markers associated with tumorigenicity and chemoresistance in the resident cancer cells. Treatment with doxorubicin supported increased tumorigenicity in the co-cultures. Together, this work demonstrates how defined microengineered matrices can serve as platforms to evaluate cell behavior, with scope for translation to in vitro assays for biological discovery and drug development.

26 June 2025 in Advanced Science
Verified
Journal Article
Open access
BSBram G. Soliman
Bram G. Soliman
PTPeilin Tian
Peilin Tian
JCJiuyu Cui
Jiuyu Cui
KKKristopher A. Kilian
Kristopher A. Kilian
J. GoodingJ. Gooding
J. Gooding
The confinement of breast cancer cells at the interface of the mammary gland lumen and its surrounding extracellular matrix is thought to be a key physical driver of cellular plasticity. The relationship between confinement‐induced solid stress and drug resistance is not well understood due to a scarcity of models that faithfully isolate the contribution of confinement on cancer cell behavior. Herein, drop‐on‐demand printing is used to uniquely replicate the spatial compartmentalization of the native cancer‐host interface: MCF‐7 breast cancer cells are dispensed within bioinert cup‐shaped alginate‐based hydrogels in high‐throughput to yield “confined” spheroids. Hydrogel confinement affects the emergence of CD44+‐CD133+ cells at the spheroid interface that drives a two‐fold increase in doxorubicin/tamoxifen resistance compared to control “unconfined” spheroids. Whilst the peripheral drug‐resistant phenotype is observed clinically, the model is unique in facilitating the emergence of this population in an in vitro setting. Pharmacological modulation of mechanotransduction proteins (YAP, myosin), abrogated the emergence of this peripheral phenotype, implicating mechanotransduction pathways as an effective way to target solid stress‐induced drug resistance. Together, this supports an “interfacial stress—stemness—drug resistance” relationship that sheds new light on the existing paradigm of spatial emergence of drug resistance in breast cancer.